XXXX of the face treated with @entity1161 : a case report and review of the literature.

@entity5 @entity1 @entity189 @entity1161
BACKGROUND: @entity189 is a rare, locally aggressive @entity5 most commonly occurring on the face. Minimal data are available regarding the role of @entity1161 ( @entity1161 ). METHODS: Cases treated with @entity1161 from 2 comprehensive @entity5 centers are reviewed along with a review of the literature. RESULTS: Three @entity1 with @entity189 of the face were treated with curative intent. One @entity1 received @entity1161 as monotherapy. Two @entity1 received postoperative @entity1161 (PORT). The @entity1 receiving @entity1161 as monotherapy experienced excellent clinical regression, had an in-field recurrence at 48-month follow-up, and is now without evidence of disease after reirradiation. Both @entity1 receiving PORT are without evidence of disease. CONCLUSION: PORT may improve local control in @entity1 with @entity189 , and its use should be considered in @entity1 with high-risk features for local recurrence. @entity1161 as monotherapy should be considered when poor cosmetic outcome can be anticipated via standard surgical treatments.
